UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Annual review of medicine, ISSN 0066-4219, 1/2016, Volume 67, Issue 1, pp. 59 - 72
somatic mutation profiling | next-generation sequencing | induction chemotherapy | graft-versus-leukemia | postremission therapy | allogeneic hematopoietic stem cell transplantation | Graft-versus-leukemia | Somatic mutation profiling | Induction chemotherapy | Allogeneic hematopoietic stem cell transplantation | Next-generation sequencing | Postremission therapy | Prognosis | Risk Assessment | Humans | Risk Factors | Hematopoietic Stem Cell Transplantation | Induction Chemotherapy | Consolidation Chemotherapy | Leukemia, Myeloid, Acute - diagnosis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Immunotherapy | Chromosome Aberrations | Mutation | Leukemia, Myeloid, Acute - therapy | Leukemia, Myeloid, Acute - genetics | Chemotherapy | Medical diagnosis | Chromosomes | Leukemia | Stem cells | Index Medicus
Journal Article
Leukemia, ISSN 0887-6924, 08/2003, Volume 17, Issue 8, pp. 1521 - 1528
Acute myeloid leukemia | Risk-adapted postremission therapy | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Chemotherapy | Pharmacology. Drug treatments | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antineoplastic agents | Acute Disease | Risk Assessment | Cytarabine - therapeutic use | Humans | Middle Aged | Male | Stem Cell Transplantation - methods | Algorithms | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Survival Analysis | Adult | Female | Remission Induction - methods | Cytogenetic Analysis | Leukemia, Myeloid - mortality | Stem Cell Transplantation - mortality | Leukemia, Myeloid - therapy | Leukemia, Myeloid - diagnosis | Mitoxantrone - therapeutic use | Index Medicus
Journal Article
International journal of hematology, ISSN 0925-5710, 8/2013, Volume 98, Issue 2, pp. 186 - 196
G-CSF combined conditioning regimen | Acute myelogenous leukemia | Autologous peripheral blood stem cell transplantation | Medicine & Public Health | Hematology | Oncology | First complete remission | Postremission therapy | Life Sciences & Biomedicine | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Autografts | Follow-Up Studies | Humans | Middle Aged | Etoposide - administration & dosage | Male | Survival Rate | Busulfan - administration & dosage | Leukemia, Myeloid, Acute - mortality | Disease-Free Survival | Antineoplastic Agents, Phytogenic - administration & dosage | Adolescent | Myeloablative Agonists - administration & dosage | Adult | Female | Aged | Retrospective Studies | Transplantation Conditioning | Peripheral Blood Stem Cell Transplantation | Leukemia, Myeloid, Acute - therapy | Granulocyte Colony-Stimulating Factor - administration & dosage | Care and treatment | Granulocyte colony-stimulating factor | Stem cells | Transplantation | Macrophage colony stimulating factor | Hematopoietic stem cells | Cancer | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 08/2010, Volume 28, Issue 24, pp. 3890 - 3898
CYTOGENETIC ABNORMALITIES | AML | ADULT PATIENTS | POSTREMISSION THERAPY | COLONY-STIMULATING FACTOR | BONE-MARROW-TRANSPLANTATION | NORMAL-TISSUES | ELDERLY-PATIENTS | EXPRESSION | UMCG Approved | ACUTE MYELOGENOUS LEUKEMIAS | Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Multivariate Analysis | Predictive Value of Tests | Translocation, Genetic | Prognosis | Humans | Leukemia, Myeloid, Acute - metabolism | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Neoplasm Proteins - metabolism | Chromosome Inversion | Proto-Oncogenes | Chromosomes, Human, Pair 3 | Karyotyping | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Odds Ratio | Leukemia, Myeloid, Acute - therapy | Monosomy | DNA-Binding Proteins | Leukemia, Myeloid, Acute - pathology | Kaplan-Meier Estimate | In Situ Hybridization, Fluorescence | Treatment Outcome | Clinical Trials as Topic | Cell Adhesion Molecules - metabolism | Remission Induction | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Chromosome Aberrations | Aged | Transcription Factors | Mutation | Genes, ras | MDS1 and EVI1 Complex Locus Protein | Leukemia, Myeloid, Acute - genetics | Index Medicus
Journal Article
Annals of oncology, ISSN 0923-7534, 2017, Volume 28, Issue 11, pp. 2793 - 2798
CEBPA | NPM1 | Acute myeloid leukemia | FLT3-ITD | Hematopoietic stem cell transplantation | Postremission therapy | Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Prospective Studies | Follow-Up Studies | Leukemia, Myeloid, Acute - pathology | Humans | Middle Aged | Hematopoietic Stem Cell Transplantation | Male | Survival Rate | Remission Induction | Transplantation, Homologous | Young Adult | fms-Like Tyrosine Kinase 3 - genetics | Adolescent | Adult | Female | Biomarkers, Tumor - genetics | CCAAT-Enhancer-Binding Proteins - genetics | Mutation | Nuclear Proteins - genetics | Leukemia, Myeloid, Acute - therapy | Leukemia, Myeloid, Acute - genetics | Index Medicus
Journal Article
Biology of blood and marrow transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 7, pp. 1218 - 1226
Hematology, Oncology and Palliative Medicine | AML | FLT3-ITD mutation | Allogeneic stem cell transplantation | Postremission therapy | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Recurrence | Prognosis | Consolidation Chemotherapy - methods | Consolidation Chemotherapy - mortality | Humans | Middle Aged | Male | Treatment Outcome | Tandem Repeat Sequences | Hematopoietic Stem Cell Transplantation - mortality | Remission Induction | Transplantation, Homologous | Leukemia, Myeloid, Acute - mortality | fms-Like Tyrosine Kinase 3 - genetics | Propensity Score | Alleles | Survival Analysis | Female | Aged | Hematopoietic Stem Cell Transplantation - methods | Leukemia, Myeloid, Acute - therapy | Leukemia, Myeloid, Acute - genetics | Tyrosine | Chemotherapy | Analysis | Stem cells | Hematopoietic stem cells | Cancer | Index Medicus
Journal Article
Annals of oncology, ISSN 0923-7534, 03/2007, Volume 18, Issue 3, pp. 529 - 534
Acute myelogenous leukemia | High-dose arabinoside | Allogeneic stem-cell transplantation | Cost-effectiveness | Postremission therapy | Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Drug Costs | Follow-Up Studies | Precursor Cell Lymphoblastic Leukemia-Lymphoma - surgery | Humans | Middle Aged | Stem Cell Transplantation - economics | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Precursor Cell Lymphoblastic Leukemia-Lymphoma - economics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Arabinonucleosides - administration & dosage | Time Factors | Antineoplastic Combined Chemotherapy Protocols - economics | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Leukemia, Myeloid, Acute - surgery | Transplantation, Homologous - economics | Kaplan-Meier Estimate | Treatment Outcome | Leukemia, Myeloid, Acute - mortality | Health Care Costs | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cost-Benefit Analysis | Taiwan | Aged | Leukemia, Myeloid, Acute - economics | Transplantation, Autologous - economics | Index Medicus
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 2007, Volume 48, Issue 5, pp. 937 - 943
AML | autologous HSCT | intensive chemotherapy | allogeneic | postremission therapy | Allogeneic | Intensive chemotherapy | Autologous HSCT | Postremission therapy | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Prognosis | Leukemia, Myeloid, Acute - pathology | Humans | Middle Aged | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Remission Induction | Transplantation, Homologous | Disease-Free Survival | Time Factors | Adult | Female | Retrospective Studies | Hematopoietic Stem Cell Transplantation - methods | Leukemia, Myeloid, Acute - therapy | Index Medicus
Journal Article
Annals of hematology, ISSN 0939-5555, 4/2019, Volume 98, Issue 4, pp. 997 - 1007
Allogeneic hematopoietic stem cell transplantation | Medicine & Public Health | Hematology | Oncology | Acute myeloid leukemia | Intermediate risk | Postremission therapy | NPM1 mut-neg CEBPA dm-neg FLT3-ITD neg | CEBPA | NPM1 | FLT3-ITD | Age Factors | Humans | Middle Aged | Risk Factors | Hematopoietic Stem Cell Transplantation | Male | Survival Rate | Leukemia, Myeloid, Acute - blood | Leukemia, Myeloid, Acute - mortality | Neoplasm, Residual | Disease-Free Survival | Allografts | Adolescent | Adult | Female | Neoplasm Proteins - blood | Retrospective Studies | Mutation | Neoplasm Proteins - genetics | Leukemia, Myeloid, Acute - therapy | Leukemia, Myeloid, Acute - genetics | Chemotherapy | Transplantation | Chromosomes | Hematopoietic stem cells | Stem cells | Cancer | Medical prognosis | Leukemia | Index Medicus
Journal Article
American journal of hematology, ISSN 0361-8609, 08/2015, Volume 90, Issue 8, pp. 719 - 724
REDUCED-INTENSITY | POSTREMISSION THERAPY | PROGNOSTIC IMPACT | POOR-PROGNOSIS | ACUTE MYELOGENOUS LEUKEMIA | 1ST REMISSION | RANDOMIZED-TRIAL | STEM-CELL TRANSPLANTATION | MYELODYSPLASTIC SYNDROME | ACUTE MYELOBLASTIC-LEUKEMIA | Life Sciences & Biomedicine | Hematology | Science & Technology | Myeloablative Agonists - therapeutic use | Prognosis | Follow-Up Studies | Humans | Middle Aged | Male | Transplantation, Homologous | Graft vs Host Disease - genetics | Graft vs Host Disease - mortality | Karyotyping | Female | Transplantation Conditioning - adverse effects | Transplantation Conditioning - methods | Graft vs Host Disease - etiology | Leukemia, Myeloid, Acute - therapy | Monosomy | Acute Disease | Leukemia, Myeloid, Acute - pathology | Europe | Hematopoietic Stem Cell Transplantation | Graft vs Host Disease - pathology | Leukemia, Myeloid, Acute - mortality | Survival Analysis | Aged | Chronic Disease | Leukemia, Myeloid, Acute - genetics | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 04/2003, Volume 97, Issue 7, pp. 1721 - 1731
high‐dose chemotherapy | de novo acute myelogenous leukemia (AML) | allogeneic stem cell transplantation | postremission therapy | autologous stem cell transplantation | De novo acute myelogenous leukemia (AML) | Allogeneic stem cell transplantation | High-dose chemotherapy | Autologous stem cell transplantation | Postremission therapy | Life Sciences & Biomedicine | Oncology | Science & Technology | Chemotherapy | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Bone marrow, stem cells transplantation. Graft versus host reaction | Pharmacology. Drug treatments | Transfusions. Complications. Transfusion reactions. Cell and gene therapy | Biological and medical sciences | Medical sciences | Antineoplastic agents | Drug Administration Schedule | Humans | Middle Aged | Male | Transplantation, Autologous | Treatment Outcome | Remission Induction | Cytarabine - administration & dosage | Transplantation, Homologous | Leukemia, Myeloid, Acute - mortality | Stem Cell Transplantation | Adolescent | Survival Analysis | Adult | Female | Transplantation Conditioning | Leukemia, Myeloid, Acute - therapy | Cancer regression | Evaluation | Transplantation | Cytarabine | Research | Stem cells | Index Medicus | Abridged Index Medicus
Journal Article